Lipids and Lipid Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 101-110 of 550 total displayed.

Past content

Corrections
Errors in Table in: Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease

Arch Intern Med 2008; 168: 1096. [Full text] [PDF]  

Medical News & Perspectives
Cholesterol Drug Controversy Continues

Mike Mitka
JAMA 2008; 299: 2266. [Extract] [Full text] [PDF]  

Original Contributions
Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome

Paul Holvoet; Duk-Hee Lee; Michael Steffes; Myron Gross; David R. Jacobs Jr
JAMA 2008; 299: 2287-2293. [Abstract] [Full text] [PDF]  

Original Investigations
Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study

Dariush Mozaffarian; Aruna Kamineni; Ronald J. Prineas; David S. Siscovick
Arch Intern Med 2008; 168: 969-978. [Abstract] [Full text] [PDF]  

Original Investigations
Genetic Predisposition, Nongenetic Risk Factors, and Coronary Infarct

Antonia Trichopoulou; Nikos Yiannakouris; Christina Bamia; Vassiliki Benetou; Dimitrios Trichopoulos; Jose M. Ordovas
Arch Intern Med 2008; 168: 891-896. [Abstract] [Full text] [PDF]  

Original Contributions
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial

Barbara V. Howard; Mary J. Roman; Richard B. Devereux; Jerome L. Fleg; James M. Galloway; Jeffrey A. Henderson; Wm. James Howard; Elisa T. Lee; Mihriye Mete; Bryce Poolaw; Robert E. Ratner; Marie Russell; Angela Silverman; Mario Stylianou; Jason G. Umans; Wenyu Wang; Matthew R. Weir; Neil J. Weissman; Charlton Wilson; Fawn Yeh; Jianhui Zhu
JAMA 2008; 299: 1678-1689. [Abstract] [Full text] [PDF] [ JAMA Report Video ] [ Author in the Room™ Teleconference ]  

Original Contributions
Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease: The EPIC Randomized Controlled Trials

Brian G. Feagan; William J. Sandborn; Ulrich Mittmann; Simon Bar-Meir; Geert D’Haens; Marc Bradette; Albert Cohen; Chrystian Dallaire; Terry P. Ponich; John W. D. McDonald; Xavier Hébuterne; Pierre Paré; Pavel Klvana; Yaron Niv; Sandro Ardizzone; Olga Alexeeva; Alaa Rostom; Gediminas Kiudelis; Johannes Spleiss; Denise Gilgen; Margaret K. Vandervoort; Cindy J. Wong; Guang Yong Zou; Allan Donner; Paul Rutgeerts
JAMA 2008; 299: 1690-1697. [Abstract] [Full text] [PDF]  

Editorials
The Great Debate of 2008—How Low to Go in Preventive Cardiology?

Eric D. Peterson; Tracy Y. Wang
JAMA 2008; 299: 1718-1720. [Extract] [Full text] [PDF]  

Commentaries
Surrogate End Points and FDA Approval: A Tale of 2 Lipid-Altering Drugs

Bruce M. Psaty; Thomas Lumley
JAMA 2008; 299: 1474-1476. [Extract] [Full text] [PDF]  

Original Investigations
Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data

Anna Bennet; Emanuele Di Angelantonio; Sebhat Erqou; Gudny Eiriksdottir; Gunnar Sigurdsson; Mark Woodward; Ann Rumley; Gordon D. O. Lowe; John Danesh; Vilmundur Gudnason
Arch Intern Med 2008; 168: 598-608. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55